Purification and identification of bovine cheese whey fatty acids exhibiting in vitro antifungal activity.
Milk lipids contain several bioactive factors exhibiting antimicrobial activity against bacteria, viruses, and fungi. In the present study, we demonstrate that free fatty acids (FFA) derived from the saponification of bovine whey cream lipids are active in vitro at inhibiting the germination of Candida albicans, a morphological transition associated with pathogenicity. This activity was found to be significantly increased when bovine FFA were enriched in non-straight-chain FFA. At low cell density, this non-straight-chain FFA-enriched fraction was also found to inhibit in a dose-dependant manner the growth of both developmental forms of C. albicans as well as the growth of Aspergillus fumigatus. Using an assay-guided fractionation, the main components responsible for these activities were isolated. On the basis of mass spectroscopic and gas chromatographic analysis, antifungal compounds were identified as capric acid (C10:0), lauroleic acid (C12:1), 11-methyldodecanoic acid (iso-C13:0), myristoleic acid (C14:1n-5), and gamma-linolenic acid (C18:3n-6). The most potent compound was gamma-linolenic acid, with minimal inhibitory concentration values of 5.4 mg/L for C. albicans and 1.3 mg/L for A. fumigatus, in standardized conditions. The results of this study indicate that bovine whey contains bioactive fatty acids exhibiting antifungal activity in vitro against 2 important human fungal pathogens.
Département de microbiologie et immunologie, Université de Montréal, C.P. 6128, succ. Centreville, Montréal, Québec, H3C 3J7, Canada. martin.clement@umontreal.ca
M
M
Clément
J
J
Tremblay
M
M
Lange
J
J
Thibodeau
P
P
Belhumeur
D000818:Animals; D000935:Antifungal Agents / Q000032:analysis / Q000302:isolation & purification / Q000494:pharmacology*; D001232:Aspergillus fumigatus / Q000187:drug effects* / Q000254:growth & development; D002176:Candida albicans / Q000187:drug effects* / Q000254:growth & development; D002417:Cattle; D002611:Cheese / Q000032:analysis; D015169:Colony Count, Microbial; D004305:Dose-Response Relationship, Drug; D005232:Fatty Acids, Volatile / Q000032:analysis / Q000302:isolation & purification / Q000494:pharmacology*; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods / Q000662:veterinary; D008826:Microbial Sensitivity Tests / Q000662:veterinary; D008892:Milk / Q000737:chemistry; D008894:Milk Proteins / Q000032:analysis / Q000737:chemistry*; D000067816:Whey Proteins; D017965:gamma-Linolenic Acid / Q000032:analysis / Q000302:isolation & purification / Q000494:pharmacology
D000935:Antifungal Agents; D005232:Fatty Acids, Volatile; D008894:Milk Proteins; D000067816:Whey Proteins; D017965:gamma-Linolenic Acid